Predictive Factors of Pseudoprogression in Vestibular Schwannoma Treated with Fractionated Stereotactic Radiotherapy

被引:0
|
作者
Lo, A. W. S. [1 ]
Nyaw, S. F. [2 ]
Mui, W. H. [2 ]
Huang, J. J. [2 ]
Kam, K. M. [3 ]
Wong, C. S. [2 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China
[3] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Happy Valley, Hong Kong, Peoples R China
来源
HONG KONG JOURNAL OF RADIOLOGY | 2019年 / 22卷 / 03期
关键词
Neuroma; acoustic; Radiotherapy; Risk factors; ACOUSTIC NEUROMAS; RADIOSURGERY; RADIATION; MANAGEMENT; EXPANSION; SURGERY;
D O I
10.12809/hkjr1916934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Fractionated stereotactic radiotherapy (FSRT) is a well-established treatment for vestibular schwannoma (VS). Tumour pseudoprogression may lead to worsening symptoms leading to the necessity of urgent salvage surgery. This study aimed to assess the predictive factors of pseudoprogression and treatment related toxicities in VS treated with FSRT. Methods: This retrospective cohort study included all patients with VS treated with FSRT between 1999 and 2015. Risk factors assessed included sex, age, previous surgical resection, tumour diameter, gross tumour volume, planning target volume, overall treatment time, equivalent dose in 2-Gy fractions, and the presence of brainstem or cerebellar compression prior to radiotherapy. Fisher's exact test and two-sample t test were used for statistical analysis. Results: Eighteen patients were included. The median follow-up time was 80.3 months. The overall disease control rate after FSRT was 94.4%. Of the 18 patients, one (5.6%) developed local tumour progression, seven (38.9%) underwent tumour pseudoprogression; and 10 (55.6%) had stable disease. Median time to tumour pseudoprogression was 8.63 months (range, 4.5-13.1 months). Tumours with pseudoprogression and those with at least stable disease had a mean diameter of 2.7 cm and 2.1 cm, respectively (p = 0.18). The mean treatment planning target volume in the pseudoprogression group was larger than that in the non-progression group with volume measured (22.2 cc vs. 10.0 cc; p = 0.04). Patients with brainstem or cerebellar compression observed on magnetic resonance imaging before radiotherapy were associated with a higher risk of pseudoprogression (p = 0.0498). The overall salvage surgery rate was 17.7%. Conclusion: Upfront surgery may be more desirable than FSRT for those surgically fit patients with considerable treatment volume and evidence of mass effect. Large prospective studies are needed to confirm our findings and to identify further predictive factors for pseudoprogression.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
  • [21] Vestibular schwannoma radiosurgery: progression or pseudoprogression?
    Regis, Jean
    Delsanti, Christine
    Roche, Pierre-Hugues
    JOURNAL OF NEUROSURGERY, 2017, 127 (02) : 374 - 376
  • [22] STEREOTACTIC FRACTIONATED RADIOTHERAPY AND LINAC RADIOSURGERY IN THE TREATMENT OF VESTIBULAR SCHWANNOMA-REPORT ABOUT BOTH STEREOTACTIC METHODS FROM A SINGLE INSTITUTION
    Kopp, Christine
    Fauser, Claudius
    Mueller, Axel
    Astner, Sabrina T.
    Jacob, Vesna
    Lumenta, Christianto
    Meyer, Bernhard
    Tonn, Joerg-Christian
    Molls, Michael
    Grosu, Anca-Ligia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1485 - 1491
  • [23] Stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neuromas
    Unger, F.
    Dominikus, K.
    Haselsberger, K.
    HNO, 2011, 59 (01) : 31 - 37
  • [24] LONG-TERM OUTCOMES OF VESTIBULAR SCHWANNOMAS TREATED WITH FRACTIONATED STEREOTACTIC RADIOTHERAPY: AN INSTITUTIONAL EXPERIENCE
    Kapoor, Sumit
    Batra, Sachin
    Carson, Kathryn
    Shuck, John
    Kharkar, Siddharth
    Gandhi, Rahul
    Jackson, Juan
    Wemmer, Jan
    Terezakis, Stephanie
    Shokek, Ori
    Kleinberg, Lawrence
    Rigamonti, Daniele
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 647 - 653
  • [25] Fractionated Stereotactic Radiotherapy of Vestibular Schwannomas Accelerates Hearing Loss
    Rasmussen, Rune
    Claesson, Magnus
    Stangerup, Sven-Eric
    Roed, Henrik
    Christensen, Ib Jarle
    Caye-Thomasen, Per
    Juhler, Marianne
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : E607 - E611
  • [26] Impact of Social Determinants of Health on Stereotactic Radiotherapy for Vestibular Schwannoma
    Desai, Amar D.
    Shah, Vraj P.
    Tseng, Christopher C.
    Povolotskiy, Roman
    Wackym, P. Ashley
    Ying, Yu-Lan Mary
    LARYNGOSCOPE, 2022, 132 (11) : 2232 - 2240
  • [27] SINGLE FRACTION VERSUS FRACTIONATED LINAC-BASED STEREOTACTIC RADIOTHERAPY FOR VESTIBULAR SCHWANNOMA: A SINGLE-INSTITUTION EXPERIENCE
    Collen, Christine
    Ampe, Ben
    Gevaert, Thierry
    Moens, Maarten
    Linthout, Nadine
    De Ridder, Mark
    Verellen, Dirk
    D'Haens, Jean
    Storme, Guy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : E503 - E509
  • [28] Management of a facial nerve schwannoma with fractionated stereotactic radiotherapy: a case report
    Mousli, Alia
    Ayadi, Hadhemi
    Yousfi, Amani
    Abidi, Rim
    Nasr, Chiraz
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2023, 22
  • [29] 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma
    T. Schneider
    J. Chapiro
    M. Lin
    J. F. Geschwind
    L. Kleinberg
    D. Rigamonti
    I. Jusué-Torres
    A. E. Marciscano
    D. M. Yousem
    European Radiology, 2016, 26 : 849 - 857
  • [30] Stereotactic radiation treatment of vestibular schwannoma: indications, limitations, and outcomes
    Conley, George S.
    Hirsch, Barry E.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2010, 18 (05) : 351 - 356